Oral lesions and conditions associated with human immunodeficiency virus infection in 1000 South Indian patients

Annals of the Academy of Medicine Singapore

Volumn 33, Issue 4 SUPPL., 2004, Pages

  Ranganathan, K ^a   Umadevi, M ^a   Saraswathi, T R ^a   Kumarasamy, N ^b   Solomon, S ^b   Johnson, N ^c  

^a RAGAS DENTAL COLLEGE AND HOSPITAL   (India)

^b VHS Medical Centre India   (India)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Candidiasis; Gender; HIV; India; Oral pigmentation

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; AGE DISTRIBUTION; BACTERIAL SKIN DISEASE; CHEILITIS; CONFERENCE PAPER; FEMALE; FUNGAL MENINGITIS; GASTROINTESTINAL DISEASE; GENITAL ULCER; GINGIVITIS; HEPATOSPLENOMEGALY; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNE STATUS; INDIA; LEUKOPLAKIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MOUTH DISEASE; MOUTH LESION; MOUTH ULCER; OCCUPATION; PERIODONTITIS; PIGMENT DISORDER; SCABIES; SEX RATIO; THRUSH; TINEA; TOXOPLASMOSIS; VERRUCA VULGARIS; VIRUS TRANSMISSION;

EID: 8144220689     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. Combating HIV/AIDS in India 2000-2001. National AIDS Control Organization 2002. Available at: http://www.naco.nic.in Accessed on June 24, 2004.
2. Ramirez-Amador V, Esquivel-Pedraza L, Sierra-Madero J, Anaya-Saavedra G, Gonzalez-Ramirez I, Ponce de Leon S. The changing clinical spectrum of human immunodeficiency virus-related oral lesions in 1000 consecutive patients: a 12-year study in a referral center in Mexico. Medicine 2003;82,1:39-50.
3. Greenspan JS. Sentinels and signposts: the epidemiology significance of the oral manifestations of HIV disease. Oral Dis 1997; 3(Suppl 1): S13-S17.
4. Weinert M, Grimes RM, Lynch DP. Oral manifestations of HIV infection. Ann Intern Med 1996;125:485-96.
5. Eyeson JD, Warnakulasuriya KA, Johnson NW. Prevalenceand incidence of oral lesions - the changing scene. Oral Dis 2000;6:267-73.
6. Greenspan D, Komaroff E, Redford M, Phelan JA, Navazesh M, Alves ME, et al. Oral mucosal lesions and HIV viral load in the Women's Interagency HIV study (WIHS). J Acquir Immune Defic Syndr 2000;25: 44-50.
7. Margiotta V, Campisi G, Mancuso S, Accurso V, Abbadess V. HIV infection, oral lesions, CD4 counts and viral load in an Italian study population. J Oral Pathol Med 1999;28:173-7.
8. Patton LL, Mckaig RG, Eron JJ, Lawerence HP, Strauss RP. Oral hairy leukoplakia and oral candidiasis as predictors of HIV viral load. AIDS 1999;13:2174-6.
9. Centers for Disease Control. HIV/AIDS surveillance report. Atlanta: CDC, 1992:1-18.
10. Campisi G, Pizzo G, Mancuso S, Margiotta V. Gender differences in HIV-related oral lesions: an Italian study [Published erratum in Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:478]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:546-51.
11. Campisi G, Pizzo G, Mancuso S, Margiotta V. Gender differences in HIV-related oral lesions: an Italian study [Published erratum in Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:478]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:546-51.
12. Shiboski CH. Epidemiology of HIV-related oral manifestations in women: a review. Oral Dis 1997;3(Suppl 1):S18-S27.
13. Melnick SL, Sherer R, Louis TA, Hillman D, Rodriguez EM, Lackman C, et al. Survival and disease progression according to the gender of patients with HIV infection. The Terry Bairn Community programs for clinical research on AIDS. JAMA 1994;272:1915-21.
14. Fleming PL, Ciesielski CA, Byers RH, Castro KG, Berkelman R. Gender differences in reported AIDS-indicative diagnosis. J Infect Dis 1993; 168:61-7.
15. Ranganathan K, Reddy BV, Kumarasamy N, Solomon S, Viswanathan R, Johnson NW. Oral lesions and conditions associated with human immuno deficiency virus infection in 300 south Indian patients. Oral Dis 2000;6:152-7.
16. 1993 revised classification systems for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41:1-19.
17. Classification and diagnostic criteria for oral lesions in HIV infection. EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus. J Oral Pathol Med 1993;22:289-91.
18. Kolokotronis A, Kioses V, Antoniades D, Mandraveli K, Doutsos I, Papanayotou P. Immunologic status in patients infected with HIV with oral candidiasis and hairy leukoplakia. Oral Surg Oral Med Oral Pathol 1994;78:41-6.
19. Schmidt-Westhausen A, Grunewald TH, Reichart PA, Pohle D. Oral manifestations in 70 German HIV infected women. Oral Dis 1997;3 (Suppl 1):S28-S30.
20. Glick M, Muzyka BC, Lurie D, Salkin LM. Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol 1994;77:344-9.
21. Shiboski CH, Hilton JF, Neuhaus JM, Canchola A, Greenspan D. Human immunodeficiency virus-related oral manifestations and gender. A longitudinal analysis. Arch Intern Med 1996;156:2249-54.
22. Prins M, Robertson JR, Brettle RP, Aguado IH, Broers B, Boufassa F, et al. Do gender differences in CD4 cell counts matter? AIDS 1999;13: 2361-4.
23. Ministry of Health and Family Welfare. Combating HIV/AIDS in India 2000-2001. India: National AIDS Control Organization. Available at: http://www.naco.nic.in/indianscene/esthiv.htm Accessed on June 24, 2004.
24. Kumarasamy N, Mahajan AP, Flanigan TP, Hemalatha R, Mayer KH, Carpenter CC, et al. Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource constrained countries. J AIDS 2002;31:378-83.
25. Nittayananta W, Chanowanna N, Winn T, Silpapojakul K, Rodklai A, Jaruratanasirikul S, et al. Co-existence between oral lesions and opportunistic systemic diseases among HIV-infected subjects in Thailand. J Oral Pathol Med 2002;31:163-8.
26. Patton LL. Sensitivity, specificity and positive predictive value of oral opportunistic infections in adults with HIV/AIDS as markers of immune suppression and viral burden. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:182-8.
27. Tappuni AR, Fleming GJP. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: A UK study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:623-8.
28. Matee MI, Scheutz F, Mosby J. Occurrence of oral lesions in relation to clinical and immunological status among HIV-infected adult Tanzanians. Oral Dis 2000;6:106-11.
29. Nittayananta W, Chanowanna N, Sripatanakul S, Winn T. Risk factors associated with oral lesions in HIV-infected heterosexual people and intravenous drug users in Thailand. J Oral Pathol Med 2001;30:224-30.
30. Bendick C, Scheifele C, Reichart PA. Oral manifestation in 101 Cambodian patients with HIV infection and AIDS. J Oral Pathol Med 2002;31:1-4.
31. Barone R, Ficarra G, Gaglioti D, Orsi A, Mazzotta F. Prevalence of oral lesions among HIV-infected intravenous drug abusers and other risk groups. Oral Surg Oral Med Oral Pathol 1990;69:169-73.
32. Moniaci D, Greco D, Flecchia G, Raiteri R, Sinicco A. Epidemiology, clinical features and prognostic value of HIV-1 related oral lesions. J Oral Pathol Med 1990;19:477-81.
33. Robinson PG, Challacombe SJ, Sheiham A, Zakrzewska JM. Is erythematous candidiasis associated with advanced HIV disease? Oral Dis 1997;3(Suppl 1):S116-S118.
34. Ramirez-Amador V, Esquivel-Pedraza L, Sierra-Madero J, Ponce-de-Leon S, Ponce-de-Leon S. Oral manifestations of HIV infection by gender and transmission category in Mexico City. J I Oral Pathol Med 1998;27:135-40.
35. Campo J, Del Romero J, Castilla J, Garcia S, Rodriguez C, Bascones A. Oral candidiasis as a clinical marker related to viral load, CD4 lymphocyte count and CD4 lymphocyte percentage in HIV-infected patients. J Oral Pathol Med 2002;31:5-10.
36. Anil S, Challacombe SJ. Oral lesions of HIV and AIDS in Asia: an overview. Oral Dis 1997;3(Suppl 1):S36-S40.
37. Langford A, Pohle HD, Zhang X, Reichart PA. Oral hyperpigmentation in HIV infected patients. Oral Surg Oral Med Oral Pathol 1989;67: 301-7.
38. Smith KJ, Skelton HG, Yeager J, Ledsky R, McCarthy W, Baxter D, et al. Cutaneous findings in HIV-1 positive patients: a 42-month prospective study. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR) [Published errata in J Am Acad Dermatol 1995;33(2 Pt 1):206 and J Am Acad Dermatol 1995;32:976]. J Am Acad Dermatol 1994;31:746-54.
39. Smith KJ, Skelton HG, Yeager J, Ledsky R, McCarthy W, Baxter D, et al. Cutaneous findings in HIV-1 positive patients: a 42-month prospective study. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR) [Published errata in J Am Acad Dermatol 1995;33(2 Pt 1):206 and J Am Acad Dermatol 1995;32:976]. J Am Acad Dermatol 1994;31:746-54.
40. Smith KJ, Skelton HG, Yeager J, Ledsky R, McCarthy W, Baxter D, et al. Cutaneous findings in HIV-1 positive patients: a 42-month prospective study. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR) [Published errata in J Am Acad Dermatol 1995;33(2 Pt 1):206 and J Am Acad Dermatol 1995;32:976]. J Am Acad Dermatol 1994;31:746-54.
41. Ceballos-Salobrena A, Gaitan-Cepeda LA, Ceballos-Garcia L, Lezama Del Valle D. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: A new face or oral AIDS? AIDS Patient Care STDS 2000;14:627-35.